TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in ADHD Rating Scale (ADHD-RS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ADHD Functional Impairment Scale (ADHD-FX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Attention Problem Scale of the Child Behavior Checklist (CBCL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional and Emotional functional and emotional measure of dysmenorrhea (FEMD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Berg's Balance Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contraction time changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Relaxation time changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximal Displacement changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Risk of developing seroma
Endpoint domain: Adverse events/effects
Primary endpoint: Change in melatonin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline in SCORAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: recommended Phase II dose (RP2D)
Endpoint domain: Resource use
Primary endpoint: Circumference change of upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly changes of Chinese Perceived Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post Procedure Pain Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in T-VASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adherence to the program of physical activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Survival rate of the medical device
Endpoint domain: Mortality/survival
Primary endpoint: Difficulty in performing spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composition of microbiota at skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of isolated restricted diffusion (IRD) in GBM patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival patterns of GBM participants with IRD
Endpoint domain: Mortality/survival
Primary endpoint: Changes in quantitative MPPF values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporomandibular Joint Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: percentage of artifacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline risk of fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in baseline quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pillow height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: numerical rating scale for pain measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infection and dehiscence of soft tissue
Endpoint domain: Adverse events/effects
Primary endpoint: questionnaire for sensory disturbance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in accuracy of cognitive task performance from baseline to 300 minutes post dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in speed of performance from baseline to 300 minutes post dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental fatigue- change in subjective mental fatigue from baseline to 300 minutes post dose
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of opioid prescriptions filled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number and Rate of Switches from ER/ LA opioids to comparator analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attendance Rate at Time 2
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sensitivity and specificity in detection of biliary tract cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Satisfaction Questionnaire for Medication (TSQM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: European Quality of Life-5 Dimensions-5 Levels (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Headache Impact Test-6 (HIT-6)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Work Productivity and Activity Impairment-General Health (WPAI-GH)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Geometric mean titers (GMT) of SARS-CoV-2 antibody concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RBD-binding IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Psychological Inflexibility
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Biomechanical and tissue viscoelastic properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative nausea intensity
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative vomiting frequency and severity
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in Insulin Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in Aerobic Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and Tolerability of MEB-1170
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical laboratory assessments for hematology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinical laboratory assessments for blood chemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose of Venetoclax and CC-486
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Discontinue Due to Reported Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Report Serious Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Do Not Show Signs of Cancer
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of participants' awareness of the risk of second primary lung cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants' awareness of lung cancer screening recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants' perception of the risk of second primary lung cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants' perception of lung cancer screening recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: microvascular acetylcholine-mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: microvascular insulin-mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of new HIV infections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of new HCV infections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of new syphilis infections
Endpoint domain: Adverse events/effects
Primary endpoint: Drinks Preceding Week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heavy Drinking Days Preceding Week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs) leading to discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically significant abnormal laboratory values
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically significant abnormal vital signs
Endpoint domain: Adverse events/effects
Primary endpoint: Delay Discounting 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay Discounting 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IOP measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symptom cluster
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respiratory Depression (RD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative Nausea and Vomiting (PONV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in quality of life summary score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Late AF recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in NYHA functional class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of echocardiographic Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute success rate of left bundle branch area pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acute complications related to the procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Disease-free survival (DFS) at three years
Endpoint domain: Mortality/survival
Primary endpoint: Final Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum alanine aminotransferase concentration values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver and biliary outcomes
Primary endpoint: Proportion of patients with detectable HDV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with liver cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Scanning session completion status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of WGS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline modified Rankin Scale (mRS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Baseline Timed-Up and Go (TUG) test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of TSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Level of fungal inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug Effect Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of adverse events (AE)/serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: CRS-R (JFK Coma Recovery Scale-Revised)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Stroke and Systemic Embolism Events
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of disease activity measured by loss of NEDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration over time (AUC) of teriparatide (PTH (1-34))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) of teriparatide (PTH 1-34)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sealant Longevity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with venous recanalization by Day 180
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Inappropriate administration of ASM
Endpoint domain: Adverse events/effects
Primary endpoint: 24 h ambulatory systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in child behavior and emotion problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in child irritability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Medical Research Council (MMRC) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pressure pain threshold after the intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure pain tolerance after the intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG power spectrum change in delta band after the intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Integration of cardiovascular health module
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Facial nerve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of Eyes With Moderate or Severe Subject-Reported Ocular Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Remission Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient experience with nursing care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge regarding harmful effects of tobacco use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Bilateral SLNs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHF functional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHF quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CHF rehospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Effectiveness of drug treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthcare retention rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants With VLNC Misperception About Harm
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants With VLNC Misperception About Cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants With VLNC Misperception About Death
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ardouin Behavioural Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Glucose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Nursing Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Self-Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hand Grip Strength Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of Catheter dysfunction requiring intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Time of first peritoneal dialysis catheter dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevention of postpartum hemorrhage (PPH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to successful deployment of device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appearance of Fine Lines and Wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: flap survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amputation level healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year Local Control Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (24 hour)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (infinity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of satisfaction and perceived treatment quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Carbon Monoxide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Retention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in Posttraumatic Stress Disorder (PTSD) Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in NK Cell Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Thigh muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Working memory behavioral performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modifications to blood-oxygen-level-dependent (BOLD) signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to cognitive recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Nasal swab test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Regional gastrointestinal metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: M1 resting state functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain Processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean hemoglobin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in overall anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Relapses of depression
Endpoint domain: Adverse events/effects
Primary endpoint: Change in resting heart rate over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in glucose levels (HbA1C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Correlation of Quality of Life surveys with the PROMPT survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ventilation variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventilation efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Alcohol use disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects discharged home alive
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of successful procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Biomarkers associated with amyloid deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent of antenatal care utilization rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of non-communicable disease screening rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of coverage of essential primary health care (PHC) services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of patients satisfied with treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glycocalyx thickness variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with serum uric acid level < 360 μmoL/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Brain structure differences in terms of white matter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain structure differences in terms of gray matter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional connectivity differences in the prefrontal-limbic pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Differences in glutamatergic neurotransmission in the anterior cingulate and prefrontal dorsolateral cortices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Interpreter Use per Clinic Visit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in protective drinking strategies
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in alcohol problems
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning